Where innovation meets health care
We are inspired by innovation to create system solutions that empower our customers and transform global health care. At Evonik, we lead in biotechnology, advance drug delivery, and are shaping the future of medical device technologies - bringing together science, sustainability, and collaboration. Through Next Generation Solutions and Advanced Precision Biosolutions, we deliver integrated approaches that enable breakthrough therapies, improve patient outcomes, and set new standards for a healthier world.
Focus on Biosolutions – Next Generation Solutions
One of our key growth areas is Advance Precision Biosolutions, where we harness the power of modern biotechnology to enable breakthrough therapies and sustainable healthcare solutions. This innovation focus is part of Evonik’s global strategy to improve health and quality of life while minimizing negative environmental impact.
Focus of Advance Precision Biosolutions
- Nucleic acid delivery - Our expertise in lipid nanoparticle (LNP) technologies and formulation development ensures stability, precision targeting, and scalability for next-generation therapies. Explore Nucleic Acid Delivery Solutions [LINK]
- Cell Culture Solutions – We empower biopharmaceutical manufacturers with advanced cell culture solutions designed to optimize media performance and process efficiency. Explore Cell Culture Solutions [LINK]
Shaping the Future of Health Care – Our Innovation Focus
Evonik has long been a leader in oral drug delivery – but that doesn’t mean we stand still. Building on our legacy innovation EUDRAGIT® functional polymers, which have set industry standards for controlled release and protection of active ingredients, we continue to push boundaries with new technologies.
In recent years, we brought EUDRACAP® ready-to-fill functional capsules to the market, enabling pharmaceutical companies a faster, more reliable way to develop oral dosage forms. Likewise, our advanced formulation platform EUDRATEC® SoluFlow addresses one of the biggest challenges in oral drug development: improving the solubility and bioavailability of poorly soluble drugs.
By constantly innovating and refining our oral drug delivery portfolio, we help customers overcome critical hurdles – from solubility enhancement to the oral delivery of large molecules – enabling more effective therapies and better patient outcomes.
Evonik delivers advanced solutions for complex parenteral drug delivery systems, helping pharmaceutical companies bring innovative therapies to market. Our expertise spans long-acting injectables (LAI), liposomes, and lipid nanoparticle (LNP) formulations - critical technologies for modern medicines.
When the COVID-19 pandemic struck, Evonik responded rapidly and decisively. We ramped up our lipid production to meet the demand for the mRNA vaccines. This flexible, collaborative approach is what drives our business today.
By working closely with startups, equipment manufacturers, and leading pharmaceutical companies, we are accelerating the development of tomorrow’s parenteral delivery systems.
Evonik empowers pharmaceutical and biotech companies with innovative solutions for advanced mammalian cell culture processes. Our expertise in media chemistry and ingredient design helps optimize performance, scalability, and efficiency for next-generation therapies.
Through a combination of cutting-edge technologies and global collaboration, we deliver system solutions that address upstream challenges in cell culture.
Evonik drives innovation in drug substance development and manufacturing as one of the world’s leading contract development and manufacturing organizations (CDMOs). We combine chemistry, engineering and biotechnology to help pharmaceutical companies worldwide manufacture even the most complex molecules.
Evonik delivers advanced material solutions that enable the development of high-performance medical devices and dermal fillers. Our expertise in polymer science and processing technologies helps customers create safer, more effective products for a wide range of healthcare applications.
We combine innovation with precision engineering to meet the most demanding requirements in medical technology.
ANY QUESTIONS? JUST CONTACT US.
"Exploring options for the development and manufacture of your cGMP small molecule drug substance or associated intermediates? Reach out and we'll help you make well informed choices as Evonik aims at getting clients practical solutions faster and easier."
Dr. Hans Henning Wenk
Head of Research, Development & Innovation
Evonik Health Care
